trending Market Intelligence /marketintelligence/en/news-insights/trending/1b6RpLFUo1MzKMEi-ebG_g2 content esgSubNav
In This List

2 Hemostemix directors resign

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


2 Hemostemix directors resign

Hemostemix Inc. said Victor Redekop and Lee Buckler resigned as directors, effective Jan. 6.

The company now has only one director, Angus Jenkins, and is in breach of Toronto Stock Exchange-Venture policies which require the company to have at least three directors.

Hemostemix requested that trading be halted until additional directors are appointed.